The only personalized medicine conference allowing you to make biomarkers and diagnostics available during every stage of clinical research, to stratify patients, prove clinical validity, and streamline the regulatory approval and reimbursement process

Biomarker Applications For Improved Clinical Trial Outcomes is a must attend event to find out how to fully integrate your drug pipeline's diagnostic needs with your trial design methods. By reconsidering how you structure and monitor partnerships between drug developers and diagnostics manufacturers, you can ensure availability of these diagnostics from the very outset of the trial process so they convey the greatest benefits.

 

Bringing together the world's leading experts on diagnostics and personalized medicine:

Carmen Bozic BIOGEN IDEC	Oscar Puig MERCK	Brandon Higgs MEDIMMUNE
Prakash Purohit IPSEN	Thomas Bocan PFIZER	Angela DeMichele University of Pennsylvania

In 2 days, you will gain actionable strategies that will allow you to:

Structure your trial design to anticipate and avoid problems while adapting to beneficial real-time data discovery.	Weed out poor responders in order to minimize time and costs while accelerating proof of biological principle
Design, identify, and use the proper diagnostics from the trial inception point in order to predetermine which patients will respond best to therapies and vaccines	Conceive and synchronize the partnerships required between pharma and diagnostics firms to boost exploratory freedom during trial stages

The agenda is currently still in production. If you would like to receive a brochure in the mail once the program is finalized,
click here. Also, make sure to opt in for email updates, to receive the latest information on program updates!

Speaking Opportunities contact: Matt Greenbaum at mailto:mgreenbaum@iirusa.com
Sponsor/Exhibit Opportunities contact: Andrew Sinetar at mailto:asinetar@iirusa.com
Media Partner Opportunities contact: Allison Rigels Nilsen at mailto:arigels@iirusa.com